Mixed-reality headsets are entering the operating room. Stryker has received FDA De Novo authorisation for SportSuite Vision — the first surgical application cleared for intraoperative use with Apple’s Vision Pro headset.
What it does
The app overlays digital content directly in the surgeon’s field of view, blending the physical operating room with arthroscopic camera images, CT data, and Stryker’s HipCheck and HipMap planning tools. The stated goal is to reduce reliance on multiple wall-mounted monitors and enable a more streamlined, ergonomic workflow.
The problem it addresses
The inefficiency is real and easy to underestimate. During arthroscopic surgery the operative view comes from a camera inside the joint, displayed on a monitor somewhere in the room. The surgeon’s hands are at the patient; their eyes are on a screen that may be positioned awkwardly relative to both.
Add preoperative CT images and a surgical plan, each on its own display, and the surgeon is repeatedly redirecting attention across the room while performing precise manipulation. Every glance is a small interruption of hand-eye coordination.
There is also a documented ergonomic cost. Surgeons hold sustained awkward neck and shoulder positions to keep monitors in view, and musculoskeletal complaints are common enough in the profession to be an occupational health concern rather than an inconvenience. Anchoring the display to the surgeon’s line of sight removes the need to contort toward a fixed screen.
First real-world use
On September 1, 2026, Stryker announced the first procedure using SportSuite Vision — a hip arthroscopy — completed at Duke Health by Dr Chad Mather III.
Hip arthroscopy is a sensible first application. It is technically demanding, relies heavily on both camera imaging and preoperative planning, and involves working in a confined joint space where spatial orientation is genuinely difficult.
What De Novo authorisation means
The regulatory route matters as much as the product. Most medical devices reach the US market through a pathway demonstrating substantial equivalence to something already cleared. That requires a predicate — and for a genuinely novel device type, none exists.
De Novo is the pathway for novel, low-to-moderate-risk device types with no predicate. The FDA evaluates the device on its own merits and, if authorised, creates a new classification.
The consequence is that this authorisation is not only about Stryker. It establishes a classification and a set of expectations that subsequent mixed-reality surgical applications can be measured against — potentially using this device as their predicate. The first through a De Novo pathway does the regulatory groundwork for everyone who follows.
Why augmented reality in surgery has been slow
The concept is not new; execution has been the obstacle. Earlier surgical AR systems used purpose-built headsets that were heavy, expensive, and limited in display quality — acceptable for demonstration, difficult to justify for routine use.
Building on consumer hardware changes that calculation. The display, tracking and processing are developed at consumer scale, and the medical device becomes the software plus the validation demonstrating it is safe and effective for a clinical purpose. That is a substantially cheaper path to a usable product.
The practical questions
Several will only be answered in routine use. Sterility and workflow is one: a headset is worn on the head, outside the sterile field, and adjusting it mid-procedure with gloved hands is not straightforward.
Comfort over long cases is another — wearing a headset for a two-hour operation is a different proposition from a demonstration. Failure modes matter too: if the headset loses tracking or runs out of battery mid-procedure, the operating room monitors must still be there, meaning the equipment is added rather than replaced.
And there is a genuine cognitive question about whether overlaying information in the visual field aids concentration or fragments it. That is an empirical matter, not something a specification sheet settles.
What to watch
This is a first-of-its-kind clearance, and real-world adoption will show how much it helps in practice. The measures that would settle it are the unglamorous ones — operative time, complication rates, whether surgeons choose to keep using it after novelty fades, and whether reported ergonomic strain actually falls.
Where surgical mixed reality goes if this works
Displaying existing images in a headset is the modest version of the idea. The more consequential applications would use the same hardware to show things a monitor cannot.
Registered overlay is the obvious next step: aligning preoperative CT or MRI data to the patient’s actual anatomy in real time, so a surgeon sees planned trajectories or structures to avoid projected onto the operative field rather than displayed alongside it. Navigation systems already do a version of this on screens, and moving it into the line of sight is a natural progression.
Beyond that lie remote proctoring, where an expert elsewhere annotates what the operating surgeon sees, and training applications capturing exactly what an experienced surgeon looks at during a case. None of that is authorised here, and each raises harder validation questions — a misaligned overlay is worse than no overlay. But the classification created by this authorisation is the foundation those applications would build on.
Regulatory authorisation establishes that a device is safe and effective for its intended use. It does not establish that it is better than what surgeons already do, and that is the question this technology now has to answer. Regulatory and device news, not medical advice.